跳至主要内容
临床试验/EUCTR2005-000832-26-SE
EUCTR2005-000832-26-SE进行中(未招募)不适用

Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study) - aGO study

Department of Endocrinology0 个研究点目标入组 300 人开始时间: 2005年3月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Graves thyrotoxicosis ( with clinical symptoms)
  • 2. Age 18 – 75 year
  • 3. TSH = 0.2 or < 0.2 and increased fT4 and/or fT3
  • 4. Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnancy or intention of pregnancy within 1 year
  • 2. Previous treatment of thyroid disease
  • 3. Thyrostatics before radioiodine treatment
  • 4. Hypersensitivity to NSAID or ASA
  • 5. Congestive heartfailure
  • 6. Impaired renal function defined as p-creatinine > 100 mmol/L
  • 7. ASAT or ALAT > 2.5 times the upper limit
  • 8. Alcholism
  • 9. Coagulopathy including warfarin treatment
  • 10. Thrombocytopenia
  • 11. Previous or active gastric ulcera
  • 12. Inflammatory bowel disease
  • 13. Diabetes retinopathy or nephropathy
  • 14. Trauma < 10 days
  • 15. Corticosteroid treated ophthalmopathy at diagnosis of thyrotoxicosis

研究者

相似试验